| Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors MG Mazza, R De Lorenzo, C Conte, S Poletti, B Vai, I Bollettini, ... Brain, behavior, and immunity 89, 594-600, 2020 | 2077 | 2020 |
| Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance J Yoshino, C Conte, L Fontana, B Mittendorfer, S Imai, KB Schechtman, ... Cell metabolism 16 (5), 658-664, 2012 | 446 | 2012 |
| Probiotics in prevention and treatment of obesity: a critical view N Kobyliak, C Conte, G Cammarota, AP Haley, I Styriak, L Gaspar, ... Nutrition & metabolism 13, 1-13, 2016 | 416 | 2016 |
| Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors M Ripa, L Galli, A Poli, C Oltolini, V Spagnuolo, A Mastrangelo, C Muccini, ... Clinical Microbiology and Infection 27 (3), 451-457, 2021 | 393 | 2021 |
| Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy F Ciceri, A Castagna, P Rovere-Querini, F De Cobelli, A Ruggeri, L Galli, ... Clinical immunology 217, 108509, 2020 | 342 | 2020 |
| Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals E Fabbrini, M Cella, SA Mccartney, A Fuchs, NA Abumrad, TA Pietka, ... Gastroenterology 145 (2), 366-374. e3, 2013 | 322 | 2013 |
| Gastric bypass and banding equally improve insulin sensitivity and β cell function D Bradley, C Conte, B Mittendorfer, JC Eagon, JE Varela, E Fabbrini, ... The Journal of clinical investigation 122 (12), 4667-4674, 2012 | 296 | 2012 |
| Residual clinical damage after COVID-19: A retrospective and prospective observational cohort study R De Lorenzo, C Conte, C Lanzani, F Benedetti, L Roveri, MG Mazza, ... PloS one 15 (10), e0239570, 2020 | 244 | 2020 |
| Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects F Magkos, X Su, D Bradley, E Fabbrini, C Conte, JC Eagon, JE Varela, ... Gastroenterology 142 (7), 1444-1446. e2, 2012 | 238 | 2012 |
| COVID-19 is associated with clinically significant weight loss and risk of malnutrition, independent of hospitalisation: a post-hoc analysis of a prospective cohort study L Di Filippo, R De Lorenzo, M D'Amico, V Sofia, L Roveri, R Mele, ... Clinical Nutrition 40 (4), 2420-2426, 2021 | 224 | 2021 |
| Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19 L Di Filippo, AM Formenti, P Rovere-Querini, M Carlucci, C Conte, ... Endocrine 68, 475-478, 2020 | 202 | 2020 |
| Insulin resistance and bone: a biological partnership C Conte, S Epstein, N Napoli Acta diabetologica 55 (4), 305-314, 2018 | 143 | 2018 |
| Vitamin D and diabetes mellitus E Maddaloni, I Cavallari, N Napoli, C Conte Vitamin D in Clinical Medicine 50, 161-176, 2018 | 135 | 2018 |
| Prevalence, characteristics, risk factors, and outcomes of invasively ventilated COVID-19 patients with acute kidney injury and renal replacement therapy EV Fominskiy, AM Scandroglio, G Monti, MG Calabro, G Landoni, ... Blood purification 50 (1), 102-109, 2021 | 125 | 2021 |
| Sclerostin regulation, microarchitecture, and advanced glycation end‐products in the bone of elderly women with type 2 diabetes A Piccoli, F Cannata, R Strollo, C Pedone, G Leanza, F Russo, V Greto, ... Journal of Bone and Mineral Research 35 (12), 2415-2422, 2020 | 112 | 2020 |
| Multiorgan insulin sensitivity in lean and obese subjects C Conte, E Fabbrini, M Kars, B Mittendorfer, BW Patterson, S Klein Diabetes care 35 (6), 1316-1321, 2012 | 103 | 2012 |
| Post-transplantation diabetes in kidney transplant recipients: an update on management and prevention C Conte, A Secchi Acta diabetologica 55, 763-779, 2018 | 101 | 2018 |
| Caloric restriction and L‐carnitine administration improves insulin sensitivity in patients with impaired glucose metabolism A Molfino, A Cascino, C Conte, C Ramaccini, FR Fanelli, A Laviano Journal of parenteral and enteral nutrition 34 (3), 295-299, 2010 | 95 | 2010 |
| Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2-A randomized phase II trial D Lorusso, G Ferrandina, N Colombo, S Pignata, A Pietragalla, C Sonetto, ... Gynecologic oncology 155 (3), 406-412, 2019 | 94 | 2019 |
| Computed tomography highlights increased visceral adiposity associated with critical illness in COVID-19 S Battisti, C Pedone, N Napoli, E Russo, V Agnoletti, SG Nigra, C Dengo, ... Diabetes Care 43 (10), E129-E130, 2020 | 93 | 2020 |
